Exploiting genomics and natural genetic variation to decode macrophage enhancers

Trends in Immunology

Volumn 36, Issue 9, 2015, Pages 507-518

  Romanoski, Casey E ^a   Link, Verena M ^a,b   Heinz, Sven ^c   Glass, Christopher K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DENDRITIC CELL; DNA METHYLATION; DNA SEQUENCE; ENHANCER REGION; ERYTHROCYTE; GENE EXPRESSION; GENETIC VARIABILITY; GENOMICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MACROPHAGE; MICROGLIA; MOLECULAR DYNAMICS; MUTATIONAL ANALYSIS; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; POINT MUTATION; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; ANTIBODY SPECIFICITY; CELL LINEAGE; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; GENETIC VARIATION; GENETICS; IMMUNOLOGY; METABOLISM; PROCEDURES;

TRANSCRIPTION FACTOR;

ANIMALS; CELL LINEAGE; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC VARIATION; GENOMICS; HUMANS; MACROPHAGES; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84940592315     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.07.006     Document Type: Review

References (127)

1. Geissmann F., et al. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
2. Wynn T.A., et al. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
3. Lucas T., et al. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 2010, 184:3964-3977.
4. Gordon S., et al. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol. Rev. 2014, 262:36-55.
5. Paolicelli R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011, 333:1456-1458.
6. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
7. Odegaard J.I., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
8. Qiu Y., et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157:1292-1308.
9. Wright J.R. Clearance and recycling of pulmonary surfactant. Am. J. Physiol. 1990, 259(2 Pt 1):L1-L12.
10. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145:341-355.
11. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4:71-78.
12. Noy R., Pollard J.W. Tumor-associated macrophages: from mechanisms to therapy. Immunity 2014, 41:49-61.
13. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
14. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
15. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immuno 2008, 8.:958-969.
16. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
17. Smale S.T. Transcriptional regulation in the innate immune system. Curr. Opin. Immunol. 2012, 24:51-57.
18. Takeda K., Akira S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 2000, 11:199-207.
19. Gautier E.L., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128.
20. Gosselin D., et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 2014, 159:1327-1340.
21. Lavin Y., et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 2014, 159:1312-1326.
22. Butovsky O., et al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nat. Neurosci. 2014, 17:131-143.
23. Okabe Y., Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 2014, 157:832-844.
24. Boyce B.F., Xing L. Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 2007, 9(Suppl. 1):S1.
25. Heintzman N.D., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007, 39:311-318.
26. Heintzman N.D., et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009, 459:108-112.
27. Consortium E.P., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
28. Andersson R., et al. An atlas of active enhancers across human cell types and tissues. Nature 2014, 507:455-461.
29. Roadmap Epigenomics Consortium, et al. Integrative analysis of 111 reference human epigenomes. Nature 2015, 518:317-330.
30. Core L.J., et al. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat. Genet. 2014, 46:1311-1320.
31. Banerji J., et al. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 1981, 27:299-308.
32. Heinz S., et al. The selection and function of cell type-specific enhancers. Nat. Rev. Mol. Cell Biol. 2015, 16:144-154.
33. Shlyueva D., et al. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 2014, 15:272-286.
34. Neph S., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489:83-90.
35. Buenrostro J.D., et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 2013, 10:1213-1218.
36. Barski A., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
37. May D., et al. Large-scale discovery of enhancers from human heart tissue. Nat. Genet. 2012, 44:89-93.
38. Dickel D.E., et al. Function-based identification of mammalian enhancers using site-specific integration. Nat. Methods 2014, 11:566-571.
39. Smith R.P., et al. Massively parallel decoding of mammalian regulatory sequences supports a flexible organizational model. Nat. Genet. 2013, 45:1021-1028.
40. Arnold C.D., et al. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 2013, 339:1074-1077.
41. Vanhille L., et al. High-throughput and quantitative assessment of enhancer activity in mammals by CapStarr-seq. Nat. Commun. 2015, 6:6905.
42. Ernst J., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49.
43. He H.H., et al. Nucleosome dynamics define transcriptional enhancers. Nat. Genet. 2010, 42:343-347.
44. Rada-Iglesias A., et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470:279-283.
45. Creyghton M.P., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21931-21936.
46. De Santa F., et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010, 8:e1000384.
47. Kim T.K., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
48. Lam M.T., et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013, 498:511-515.
49. Schaukowitch K., et al. Enhancer RNA facilitates NELF release from immediate early genes. Mol. Cell 2014, 56:29-42.
50. Hsieh C.L., et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:7319-7324.
51. Li W., et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013, 498:516-520.
52. Kaikkonen M.U., et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 2013, 51:310-325.
53. Bonn S., et al. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat. Genet. 2012, 44:148-156.
54. Kieffer-Kwon K.R., et al. Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell 2013, 155:1507-1520.
55. Wang D., et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
56. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
57. Chan H.M., La Thangue N.B. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 2001, 114:2363-2373.
58. Heinz S., et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 2010, 38:576-589.
59. Scott E.W., et al. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 1994, 265:1573-1577.
60. McKercher S.R., et al. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 1996, 15:5647-5658.
61. Lara-Astiaso D., et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 2014, 345:943-949.
62. Kazemian M., et al. Widespread evidence of cooperative DNA binding by transcription factors in Drosophila development. Nucleic Acids Res. 2013, 41:8237-8252.
63. Cheng Y., et al. Principles of regulatory information conservation between mouse and human. Nature 2014, 515:371-375.
64. Stergachis A.B., et al. Conservation of trans-acting circuitry during mammalian regulatory evolution. Nature 2014, 515:365-370.
65. McConnell S.C., et al. Human globin knock-in mice complete fetal-to-adult hemoglobin switching in postnatal development. Mol. Cell Biol. 2011, 31:876-883.
66. Peterson K.R., et al. Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human beta-globin locus display proper developmental control of human globin genes. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:7593-7597.
67. Dowen J.M., et al. Control of cell identity genes occurs in insulated neighborhoods in mammalian chromosomes. Cell 2014, 159:374-387.
68. Hnisz D., et al. Super-enhancers in the control of cell identity and disease. Cell 2013, 155:934-947.
69. Whyte W.A., et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
70. Parker S.C., et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:17921-17926.
71. Pott S., Lieb J.D. What are super-enhancers?. Nat. Genet. 2015, 47:8-12.
72. Forrester W.C., et al. Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res. 1987, 15:10159-10177.
73. Grosveld F., et al. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 1987, 51:975-985.
74. Tuan D., et al. The 'beta-like-globin' gene domain in human erythroid cells. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:6384-6388.
75. May G., et al. Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell Stem Cell 2013, 13:754-768.
76. Doulatov S., et al. Hematopoiesis: a human perspective. Cell Stem Cell 2012, 10:120-136.
77. Gifford C.A., et al. Transcriptional and epigenetic dynamics during specification of human embryonic stem cells. Cell 2013, 153:1149-1163.
78. Koche R.P., et al. Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011, 8:96-105.
79. Tsankov A.M., et al. Transcription factor binding dynamics during human ES cell differentiation. Nature 2015, 518:344-349.
80. Xu J., et al. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev. 2009, 23:2824-2838.
81. Zhang J.A., et al. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 2012, 149:467-482.
82. Ziller M.J., et al. Dissecting neural differentiation regulatory networks through epigenetic footprinting. Nature 2015, 518:355-359.
83. Anguita E., et al. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J. 2004, 23:2841-2852.
84. Grass J.A., et al. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8811-8816.
85. Gao X., et al. Gata2 cis-element is required for hematopoietic stem cell generation in the mammalian embryo. J. Exp. Med. 2013, 210:2833-2842.
86. Maurano M.T., et al. Widespread site-dependent buffering of human regulatory polymorphism. PLoS Genet. 2012, 8:e1002599.
87. Tall A.R., Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 2015, 15:104-116.
88. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1:135-145.
89. Heinz S., et al. Effect of natural genetic variation on enhancer selection and function. Nature 2013, 503:487-492.
90. Ostuni R., et al. Latent enhancers activated by stimulation in differentiated cells. Cell 2013, 152:157-171.
91. Ghisletti S., et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 2010, 32:317-328.
92. Garber M., et al. A high-throughput chromatin immunoprecipitation approach reveals principles of dynamic gene regulation in mammals. Mol. Cell 2012, 47:810-822.
93. Cirillo L.A., et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
94. Mullen A.C., et al. Master transcription factors determine cell-type-specific responses to TGF-beta signaling. Cell 2011, 147:565-576.
95. Samstein R.M., et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012, 151:153-166.
96. John S., et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 2011, 43:264-268.
97. Barish G.D., et al. Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev. 2010, 24:2760-2765.
98. Vahedi G., et al. STATs shape the active enhancer landscape of T cell populations. Cell 2012, 151:981-993.
99. Trompouki E., et al. Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 2011, 147:577-589.
100. Brunkow M.E., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
101. + T regulatory cells. Nat. Immunol. 2003, 4:337-342.
102. + T helper cells. Cell 2006, 126:1121-1133.
103. Szabo S.J., et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
104. Ciofani M., et al. A validated regulatory network for Th17 cell specification. Cell 2012, 151:289-303.
105. Li P., et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 2012, 490:543-546.
106. Kasowski M., et al. Variation in transcription factor binding among humans. Science 2010, 328:232-235.
107. McVicker G., et al. Identification of genetic variants that affect histone modifications in human cells. Science 2013, 342:747-749.
108. Gautier E.L., et al. Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival. J. Exp. Med. 2014, 211:1525-1531.
109. Makwana M., et al. Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS. J. Neurosci. 2007, 27:11201-11213.
110. Hindorff L.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9362-9367.
111. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
112. Farh K.K., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 2015, 518:337-343.
113. Trynka G., et al. Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 2013, 45:124-130.
114. Kasowski M., et al. Extensive variation in chromatin states across humans. Science 2013, 342:750-752.
115. Kilpinen H., et al. Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science 2013, 342:744-747.
116. Lee M.N., et al. Common genetic variants modulate pathogen-sensing responses in human dendritic cells. Science 2014, 343:1246980.
117. Raj T., et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 2014, 344:519-523.
118. Ye C.J., et al. Intersection of population variation and autoimmunity genetics in human T cell activation. Science 2014, 345:1254665.
119. Cookson W., et al. Mapping complex disease traits with global gene expression. Nat. Rev. Genet. 2009, 10:184-194.
120. Fairfax B.P., et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 2014, 343:1246949.
121. Romanoski C.E., et al. Systems genetics analysis of gene-by-environment interactions in human cells. Am. J. Hum. Genet. 2010, 86:399-410.
122. Orozco L.D., et al. Unraveling inflammatory responses using systems genetics and gene-environment interactions in macrophages. Cell 2012, 151:658-670.
123. Harismendy O., et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011, 470:264-268.
124. Hawkins R.D., et al. Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization. Immunity 2013, 38:1271-1284.
125. Lieberman-Aiden E., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
126. Sanyal A., et al. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
127. Zhou H.Y., et al. A Sox2 distal enhancer cluster regulates embryonic stem cell differentiation potential. Genes Dev. 2014, 28:2699-2711.